Tim-3 Promotes Listeria monocytogenes Immune Evasion by Suppressing Major Histocompatibility Complex Class I
Z Wang, G Li, S Dou, Y Zhang, Y Liu… - The Journal of …, 2020 - academic.oup.com
Background T-cell immunoglobulin and mucin protein 3 (Tim-3) is an immune checkpoint
inhibitor that has therapeutic implications for many tumors and infectious diseases …
inhibitor that has therapeutic implications for many tumors and infectious diseases …
Tim-3 inhibits macrophage control of Listeria monocytogenes by inhibiting Nrf2
Z Wang, D Sun, G Chen, G Li, S Dou, R Wang… - Scientific reports, 2017 - nature.com
T cell immunoglobulin mucin-3 (Tim-3) is an immune checkpoint inhibitor and its
dysregulation has been related to T cell tolerance and many immune disorders, such as …
dysregulation has been related to T cell tolerance and many immune disorders, such as …
Tim-3 directly enhances CD8 T cell responses to acute Listeria monocytogenes infection
JV Gorman, G Starbeck-Miller, NLL Pham… - The Journal of …, 2014 - journals.aai.org
T cell Ig and mucin domain (Tim) 3 is a surface molecule expressed throughout the immune
system that can mediate both stimulatory and inhibitory effects. Previous studies have …
system that can mediate both stimulatory and inhibitory effects. Previous studies have …
TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action
Cancer immunotherapy has produced impressive clinical results in recent years. Despite the
success of the checkpoint blockade strategies targeting cytotoxic T lymphocyte antigen 4 …
success of the checkpoint blockade strategies targeting cytotoxic T lymphocyte antigen 4 …
Tim-3 promotes tumor-promoting M2 macrophage polarization by binding to STAT1 and suppressing the STAT1-miR-155 signaling axis
X Jiang, T Zhou, Y Xiao, J Yu, S Dou, G Chen… - …, 2016 - Taylor & Francis
ABSTRACT T cell Ig mucin-3 (Tim-3), an immune checkpoint inhibitor, shows therapeutic
potential. However, the molecular mechanism by which Tim-3 regulates immune responses …
potential. However, the molecular mechanism by which Tim-3 regulates immune responses …
Monoclonal antibody against human Tim‐3 enhances antiviral immune response
G Li, C Hou, S Dou, J Zhang, Y Zhang… - Scandinavian …, 2019 - Wiley Online Library
T cell immunoglobulin and mucin domain protein 3 (Tim‐3) is an immune checkpoint
inhibitor in T cells and innate immune cells. The deregulated upregulation of Tim‐3 is …
inhibitor in T cells and innate immune cells. The deregulated upregulation of Tim‐3 is …
Emerging Tim-3 functions in antimicrobial and tumor immunity
K Sakuishi, P Jayaraman, SM Behar, AC Anderson… - Trends in …, 2011 - cell.com
T cell immunoglobulin-3 (Tim-3) has been identified as a marker of differentiated interferon-γ-
producing CD4+ T helper type 1 and CD8+ T cytotoxic type 1 cells. The interaction of Tim-3 …
producing CD4+ T helper type 1 and CD8+ T cytotoxic type 1 cells. The interaction of Tim-3 …
Tim-3 relieves experimental autoimmune encephalomyelitis by suppressing MHC-II
L Tang, G Li, Y Zheng, C Hou, Y Gao, Y Hao… - Frontiers in …, 2022 - frontiersin.org
Tim-3, an immune checkpoint inhibitor, is widely expressed on the immune cells and
contributes to immune tolerance. However, the mechanisms by which Tim-3 induces …
contributes to immune tolerance. However, the mechanisms by which Tim-3 induces …
Tim3 binding to galectin-9 stimulates antimicrobial immunity
P Jayaraman, I Sada-Ovalle, S Beladi… - Journal of Experimental …, 2010 - rupress.org
T cell immunoglobulin and mucin domain 3 (Tim3) is a negative regulatory molecule that
inhibits effector TH1-type responses. Such inhibitory signals prevent unintended tissue …
inhibits effector TH1-type responses. Such inhibitory signals prevent unintended tissue …
Role of Tim-3 in regulating tumorigenesis, inflammation, and antitumor immunity therapy
Y Cao, Q Li, H Liu, X He, F Huang… - Cancer Biomarkers, 2021 - content.iospress.com
Over the past decade, cancer immunotherapy, such as immune checkpoint inhibitors (ICRs),
has attained considerable progresses in clinical practice. T-cell immunoglobulin and mucin …
has attained considerable progresses in clinical practice. T-cell immunoglobulin and mucin …